Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome

被引:0
作者
Yang, Yanting [1 ]
Liu, Lin [1 ]
Hu, Ning [1 ]
Huo, Huyan [1 ]
Yang, Xin [2 ]
Wang, Fang [3 ]
机构
[1] Lanzhou Univ, Clin Med Coll 2, Dept Obstet & Gynecol, Lanzhou, Peoples R China
[2] Lanzhou Univ, Clin Med Coll 2, Dept Reprod Med, Lanzhou, Peoples R China
[3] Lanzhou Univ, Hosp 2, Dept Reprod Med, Lanzhou, Peoples R China
来源
FRONTIERS IN GLOBAL WOMENS HEALTH | 2025年 / 6卷
基金
中国国家自然科学基金;
关键词
polycystic ovary syndrome; depression; anxiety; sleep disorders; mental health; QUALITY-OF-LIFE; HEALTH; SLEEP; PREVALENCE; DISORDERS; MANAGEMENT; SYMPTOMS; HORMONES; IMPACT;
D O I
10.3389/fgwh.2025.1520641
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine disorders among women of reproductive age, often accompanied by a series of symptoms such as hirsutism, hair loss, menstrual disorders and obesity, resulting in an increasing risk of depression and anxiety in such patients. Methods: A total of 413 patients in the Reproductive Medicine Center of the Second Hospital of Lanzhou University from June 2021 to June 2023 were enrolled. We collected sociodemographic information and lifestyle-related factors using a structured questionnaire. Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Scale (GAD-7) were used to evaluate the psychological status of the subjects. Sleep-related variables were assessed using the Pittsburgh Sleep Quality Index (PSQI), and metabolic measures were collected from patients' medical records. Results: Compared with the control group, PCOS patients were younger, the average age was (27.39 +/- 3.48) years old, and the BMI value was higher, the difference was statistically significant (p < 0.05). The proportions of depression and anxiety in PCOS patients were 47.7% and 39.9%, respectively. In PCOS patients with depressive anxiety symptoms, the proportions of mild, moderate, moderately severe and severe depression were 31.6%, 12.4%, 1.6% and 2.1%, respectively. The proportions of mild, moderate, moderately severe and severe anxiety were 30.6%, 6.2%, 1.0% and 2.1%, respectively. Depression was significantly associated with serum free triiodothyronine (FT3) OR (95% CI) = 3.33 (1.30-8.55), sleep duration 4.99 (1.45-17.23) and daytime dysfunction 8.24 (3.53-19.22). Anxiety was significantly associated with daytime dysfunction OR (95% CI) = 3.45 (1.78-6.70). No association was found between mental health and other metabolic characteristics in PCOS patients (p > 0.05). Conclusion: According to the results of the current study, a high proportion of women with PCOS have mental health disorders, and there is a significant correlation between mental health disorders and sleep conditions.
引用
收藏
页数:11
相关论文
共 38 条
  • [1] Management of polycystic ovary syndrome must include assessment and treatment of mental health symptoms
    Alur-Gupta, Snigdha
    Dokras, Anuja
    Cooney, Laura G.
    [J]. FERTILITY AND STERILITY, 2024, 121 (03) : 384 - 399
  • [2] Considerations in the Treatment of Depression and Anxiety in Women with PCOS
    Alur-Gupta, Snigdha
    Dokras, Anuja
    [J]. SEMINARS IN REPRODUCTIVE MEDICINE, 2023, 41 (01/02) : 37 - 44
  • [3] Impact of polycystic ovary syndrome on eating behavior, depression and health related quality of life: A cross-sectional study in Riyadh
    Asdaq, Syed Mohammed Basheeruddin
    Jomah, Shahamah
    Hasan, Reem
    Al-Baroudi, Danah
    Alharbi, Mai
    Alsubaie, Sarah
    Buhamad, Maryam Hassan
    Alyahya, Bdoor
    Al-Yamani, Mohammed Jaber
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2020, 27 (12) : 3342 - 3347
  • [4] Sleep and Mental Disorders: A Meta-Analysis of Polysomnographic Research
    Baglioni, Chiara
    Nanovska, Svetoslava
    Regen, Wolfram
    Spiegelhalder, Kai
    Feige, Bernd
    Nissen, Christoph
    Reynolds, Charles F., III
    Riemann, Dieter
    [J]. PSYCHOLOGICAL BULLETIN, 2016, 142 (09) : 969 - 990
  • [5] The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
    Balen, Adam H.
    Morley, Lara C.
    Misso, Marie
    Franks, Stephen
    Legro, Richard S.
    Wijeyaratne, Chandrika N.
    Stener-Victorin, Elisabet
    Fauser, Bart C. J. M.
    Norman, Robert J.
    Teede, Helena
    [J]. HUMAN REPRODUCTION UPDATE, 2016, 22 (06) : 687 - 708
  • [6] Health-Related Quality of Life in Patients with Polycystic Ovary Syndrome (PCOS): A Model-Based Study of Predictive Factors
    Bazarganipour, Fatemeh
    Ziaei, Saeide
    Montazeri, Ali
    Foroozanfard, Fatemeh
    Kazemnejad, Anoshirvan
    Faghihzadeh, Soghrat
    [J]. JOURNAL OF SEXUAL MEDICINE, 2014, 11 (04) : 1023 - 1032
  • [7] Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder
    Berent, Dominika
    Zboralski, Krzysztof
    Orzechowska, Agata
    Galecki, Piotr
    [J]. MOLECULAR BIOLOGY REPORTS, 2014, 41 (04) : 2419 - 2425
  • [8] High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
    Cooney, Laura G.
    Lee, Iris
    Sammel, Mary D.
    Dokras, Anuja
    [J]. HUMAN REPRODUCTION, 2017, 32 (05) : 1075 - 1091
  • [9] Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome
    Dokras, Anuja
    Stener-Victorin, Elisabeth
    Yildiz, Bulent O.
    Li, Rong
    Ottey, Sasha
    Shah, Duru
    Epperson, Neill
    Teede, Helena
    [J]. FERTILITY AND STERILITY, 2018, 109 (05) : 888 - 899
  • [10] Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis
    Dokras, Anuja
    Clifton, Shari
    Futterweit, Walter
    Wild, Robert
    [J]. FERTILITY AND STERILITY, 2012, 97 (01) : 225 - U381